目的探讨康复评定和治疗对吉兰·巴雷综合征的作用。
ObjectiveTo explore the effect of rehabilitation evaluation and treatment on guillain-barre syndrome.
目的：探讨电生理检查对吉兰巴雷综合征（GBS）患者的临床价值。
Objective:To explore the clinical value of electrophysiological detection for GBS.
目的探讨吉兰·巴雷综合征(GBS)临床分期分型与T淋巴细胞亚群变化的相关性。
Objective To study the correlation between t lymphocyte subsets and clinical stage and typing of the patients with Guillian-Barre syndrome (GBS).
在一些地方，伴随病毒而来的，是新生畸形小头婴儿，以及吉兰—巴雷综合征病例激增。
Arrival of the virus in some places has been associated with a steep increase in the birth of babies with abnormally small heads and in cases of Guillain-Barre syndrome.
介绍吉兰·巴雷综合征(GBS)病因治疗的循证医学证据，主要包括血浆置换、静脉注射免疫球蛋白、糖皮质激素。
To introduce etiologic therapy in evidence-based medicine (EBM) practice for Guillain-Barr syndrome (GBS), mainly including plasma exchange, intravenous immunoglobulin and glucocorticoid.
方法选择临床确诊的吉兰-巴雷综合征患者进行临床分期与分型，并用流式细胞仪检测其外周血T淋巴细胞亚群的相对计数。
Methods The clinical stage and clinical typing of patients with GBS were observed; T lymphocyte subsets in peripheral blood of patients with GBS were counted by flow cytometry.
1966年，一位奥地利医生AndreasRett（安德里亚。 雷特）第一次描述了一种复杂的神经紊乱综合征，雷特氏综合症。
Rett syndrome is a complex neurological disorder that was first described in 1966 by Andreas Rett, an Austrian doctor.
这项试验对普拉格雷的命运至关重要，因为半数以上的急性冠脉综合征的患者不想安装支架。
The trial could be crucial for the fate of prasugrel because more than half of patients treated for acute coronary syndrome do not receive stents.
阿耳斯特·雷姆(氏)综合征中对足部感觉的显著性保护作用可能为广泛糖尿病人群对神经病变的不同感受性的原因提高了线索。
The striking preservation of protective foot sensation in Alstrom syndrome may provide a clue to the causes of differential susceptibility to neuropathy in the wider diabetic population.
氯吡格雷是一种抗血小板药物，是新型二磷酸腺苷受体拮抗剂，已广泛应用于急性冠脉综合征和经皮冠状动脉介入治疗的抗血栓治疗。
Clopidogrel is a kind of drug to resistant platelet, it is a new ADP receptor resistant. It has been used in acute coronary syndrome and percutaneous coronary intervention patients widely.
氯吡格雷是一种抗血小板药物，是新型二磷酸腺苷受体拮抗剂，已广泛应用于急性冠脉综合征和经皮冠状动脉介入治疗的抗血栓治疗。
Clopidogrel is a kind of drug to resistant platelet, it is a new ADP receptor resistant. It has been used in acute coronary syndrome and percutaneous coronary intervention patients widely.
应用推荐